Literature DB >> 16680012

Key inflammatory signaling pathways are regulated by the proteasome.

Jing Shen1, Julia Reis, David C Morrison, Christopher Papasian, Sreekumar Raghavakaimal, Christopher Kolbert, Asaf A Qureshi, Stefanie N Vogel, Nilofer Qureshi.   

Abstract

Lipopolysaccharide (LPS) is a major structural component of all Gram-negative organisms and has been implicated in Gram-negative sepsis and septic shock. In the present study, Affymetrix microarray analysis of RNA derived from murine macrophages treated with LPS in the absence or presence of the proteasome inhibitor lactacystin revealed that the vast majority of genes regulated by LPS is under control of the proteasome. Analysis of the data has revealed that the products of these genes participate in 14 distinct signaling pathways. This represents a novel approach to the identification of signaling pathways that are both toll-like receptor 4- and proteasome-dependent and may lead to the development of new drug targets in Gram-negative sepsis and septic shock.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16680012     DOI: 10.1097/01.shk.0000209554.46704.64

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  30 in total

1.  Differential effects of lactacystin on cytokine production in activated Jurkat cells and murine splenocytes.

Authors:  Cheryl E Rockwell; Nilofer Qureshi
Journal:  Cytokine       Date:  2010-04-27       Impact factor: 3.861

Review 2.  Proteasome protease mediated regulation of cytokine induction and inflammation.

Authors:  Nilofer Qureshi; David C Morrison; Julia Reis
Journal:  Biochim Biophys Acta       Date:  2012-06-19

3.  Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo.

Authors:  Sven Klaschik; Debra Tross; Dennis M Klinman
Journal:  J Leukoc Biol       Date:  2009-01-29       Impact factor: 4.962

4.  A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model.

Authors:  Julia Reis; Xiaoyu Tan; Rongjie Yang; Cheryl E Rockwell; Christopher J Papasian; Stefanie N Vogel; David C Morrison; Asaf A Qureshi; Nilofer Qureshi
Journal:  Innate Immun       Date:  2008-10       Impact factor: 2.680

5.  Generation and purification of highly specific antibodies for detecting post-translationally modified proteins in vivo.

Authors:  Swathi Arur; Tim Schedl
Journal:  Nat Protoc       Date:  2014-01-23       Impact factor: 13.491

6.  Age influences inflammatory responses, hemodynamics, and cardiac proteasome activation during acute lung injury.

Authors:  Helena M Linge; Ji Young Lee; Kanta Ochani; Kiyokazu Koga; Nina Kohn; Kaie Ojamaa; Saul R Powell; Edmund J Miller
Journal:  Exp Lung Res       Date:  2015-04-06       Impact factor: 2.459

7.  Of Mice and Men: Proteasome's Role in LPS-Induced Inflammation and Tolerance.

Authors:  Neerupma Silswal; Julia Reis; Asaf A Qureshi; Christopher Papasian; Nilofer Qureshi
Journal:  Shock       Date:  2017-04       Impact factor: 3.454

8.  Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma.

Authors:  Dai Maruyama; Takashi Watanabe; Yuji Heike; Kumiko Nagase; Noriko Takahashi; Satoshi Yamasaki; Fusako Waki; Hiroki Yokoyama; Sung-Won Kim; Yukio Kobayashi; Shin Aizawa; Kensei Tobinai
Journal:  Int J Hematol       Date:  2008-11-07       Impact factor: 2.490

9.  Comparative genomics RNAi screen identifies Eftud2 as a novel regulator of innate immunity.

Authors:  Lesly De Arras; Rebecca Laws; Sonia M Leach; Kyle Pontis; Jonathan H Freedman; David A Schwartz; Scott Alper
Journal:  Genetics       Date:  2013-12-20       Impact factor: 4.562

10.  Targeting the ubiquitin proteasome pathway for the treatment of septic shock in patients.

Authors:  Jan Brun; Douglas A Gray
Journal:  Crit Care       Date:  2009-08-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.